平衡法：干预后双重抗血小板疗法的合理方法。

Q3 Medicine

The Journal of the Association of Physicians of India Pub Date : 2024-11-01 DOI:10.59556/japi.72.0668

Nihar Mehta, Divya Samat

{"title":"平衡法：干预后双重抗血小板疗法的合理方法。","authors":"Nihar Mehta, Divya Samat","doi":"10.59556/japi.72.0668","DOIUrl":null,"url":null,"abstract":"Balancing the risks of ischemic and bleeding events in patients who have undergone coronary angioplasty with drug-eluting stents (DES) is a delicate task. Individuals recovering from myocardial infarction are at increased risk of recurrent ischemic events, highlighting the potential benefits of rigorous secondary prevention measures.1 Dual antiplatelet therapy (DAPT), combining aspirin with P2Y12 inhibitors such as clopidogrel or ticagrelor, forms the cornerstone of post-percutaneous coronary intervention (PCI) care aimed at preventing stent thrombosis and lowering the risk of ischemic events. Current medical guidelines recommend a 6-month duration of DAPT for stable coronary disease and 12 months for acute coronary syndrome (ACS).","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 11","pages":"11-13"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Balancing Act: A Rational Approach to Postintervention Dual Antiplatelet Therapy.\",\"authors\":\"Nihar Mehta, Divya Samat\",\"doi\":\"10.59556/japi.72.0668\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Balancing the risks of ischemic and bleeding events in patients who have undergone coronary angioplasty with drug-eluting stents (DES) is a delicate task. Individuals recovering from myocardial infarction are at increased risk of recurrent ischemic events, highlighting the potential benefits of rigorous secondary prevention measures.1 Dual antiplatelet therapy (DAPT), combining aspirin with P2Y12 inhibitors such as clopidogrel or ticagrelor, forms the cornerstone of post-percutaneous coronary intervention (PCI) care aimed at preventing stent thrombosis and lowering the risk of ischemic events. Current medical guidelines recommend a 6-month duration of DAPT for stable coronary disease and 12 months for acute coronary syndrome (ACS).\",\"PeriodicalId\":22693,\"journal\":{\"name\":\"The Journal of the Association of Physicians of India\",\"volume\":\"72 11\",\"pages\":\"11-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Association of Physicians of India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.59556/japi.72.0668\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Association of Physicians of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59556/japi.72.0668","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

平衡使用药物洗脱支架（DES）进行冠状动脉成形术的患者发生缺血性和出血事件的风险是一项棘手的任务。1 将阿司匹林与氯吡格雷或替卡格雷等 P2Y12 抑制剂结合使用的双联抗血小板疗法（DAPT）是经皮冠状动脉介入治疗（PCI）术后护理的基石，旨在预防支架血栓形成并降低缺血性事件的风险。目前的医疗指南建议，稳定型冠心病的 DAPT 疗程为 6 个月，急性冠状动脉综合征（ACS）的 DAPT 疗程为 12 个月。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Balancing Act: A Rational Approach to Postintervention Dual Antiplatelet Therapy.

Balancing the risks of ischemic and bleeding events in patients who have undergone coronary angioplasty with drug-eluting stents (DES) is a delicate task. Individuals recovering from myocardial infarction are at increased risk of recurrent ischemic events, highlighting the potential benefits of rigorous secondary prevention measures.¹ Dual antiplatelet therapy (DAPT), combining aspirin with P2Y12 inhibitors such as clopidogrel or ticagrelor, forms the cornerstone of post-percutaneous coronary intervention (PCI) care aimed at preventing stent thrombosis and lowering the risk of ischemic events. Current medical guidelines recommend a 6-month duration of DAPT for stable coronary disease and 12 months for acute coronary syndrome (ACS).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Journal of the Association of Physicians of India Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

509